Join Proteona at the Global Cluster Partnering (GCP) – Healthcare
Innovative AI-driven genomic and proteomic analysis platform for improving cell therapy and immuno-oncology
Meet Proteona at the Global Cluster Partnering (GCP) – Healthcare event, taking place virtually from the 26th to the 27th of August 2020.
Proteona CEO Dr. Andreas Schmidt will be available during the event to share the latest progress at Proteona and the upcoming partnering and investment opportunities.
The GCP – Health care event is co-organized renowned European and international biotech networks including Ascrion, BIO Deutschland, and BioRN. It attracts an international audience from healthcare-related industries such as biopharma, medtech, and biotech.
Secure your meeting slot with Proteona now!
For media queries, please contact:
Dr Andreas Schmidt
Proteona Pte. Ltd. is a biomedical company in Singapore, Germany, and the US that is pioneering the use of single cell proteogenomics to improve clinical outcomes in cancer. Using a combination of innovative single cell assays and AI-assisted bioinformatics, Proteona provides a comprehensive sample to answer service that enables users to phenotype cells using standard protein markers and gain a deeper understanding of cell activity based upon their gene expression profiles. Proteona is a spin-off from the National University of Singapore (NUS) and the Agency for Science, Technology and Research (A*STAR). Proteona is leading an international alliance to develop neutralizing antibodies against coronaviruses including SARS-CoV-2. In addition, Proteona supports partners developing COVID-19 therapies and vaccines by providing single cell immune profiling services.